Banking of perinatal mesenchymal stem/stromal cells for stem cell-based personalized medicine over lifetime: Matters arising

doi:10.4252/wjsc.v15.i4.105

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2389)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

110

WORD

HTML

1216

Figures (1-2)

126

Tables (1-1)

Sum=1574

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

130

Download

274

Sum=404

Publishing Process of This Article

Item

Count

Browse

143

Download

268

Sum=411

Apr 26, 2023 (publication date) through May 1, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Opinion Review

World J Stem Cells. Apr 26, 2023; 15(4): 105-119
Published online Apr 26, 2023. doi: 10.4252/wjsc.v15.i4.105

Open in New Tab Full Size Figure Download Figure

Figure 1 Operating model of banking perinatal mesenchymal stromal/stem cells. Perinatal mesenchymal stromal/stem cells banking process includes the perinatal tissue collection, isolation, stem cell expansion, testing, preparation, and storage. The quality assurance programs are performed during the whole banking process. MSCs: Mesenchymal stromal/stem cells.

Open in New Tab Full Size Figure Download Figure

Figure 2 Strategies and administrative requirements for high-quality stem cell banks. MSCs: Mesenchymal stromal/stem cells; DMSO: Dimethyl sulfoxide.

Citation: Li CH, Zhao J, Zhang HY, Wang B. Banking of perinatal mesenchymal stem/stromal cells for stem cell-based personalized medicine over lifetime: Matters arising. World J Stem Cells 2023; 15(4): 105-119
URL: https://www.wjgnet.com/1948-0210/full/v15/i4/105.htm
DOI: https://dx.doi.org/10.4252/wjsc.v15.i4.105